Acumen Pharmaceuticals
ABOS
#10834
Rank
C$19.34 M
Marketcap
C$0.27
Share price
-3.52%
Change (1 day)
-87.92%
Change (1 year)

Earnings for Acumen Pharmaceuticals (ABOS)

Earnings in 2026 (TTM): -C$0.14 Billion

According to Acumen Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$0.17 Billion a decrease over its 2024 earnings that were of -C$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acumen Pharmaceuticals from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.14 Billion-16.7%
2025 -C$0.17 Billion19.18%
2024 -C$0.15 Billion118.3%
2023 -C$64.56 Million-0.5%
2022 -C$64.88 Million-173.58%
2021 C$88.16 M-876.96%
2020 -C$11.35 Million